COVID-19: An overview and a clinical update

Area of Science:

• * Infectious Diseases
• * Virology
• * Public Health

Background:

• * The rapid global spread of coronavirus disease-2019 (COVID-19), caused by SARS-CoV-2, originated in Wuhan, China.
• * Transmission occurs through close contact and respiratory droplets, posing significant public health risks.
• * Early research indicates potential treatments like dexamethasone and remdesivir, though supportive care remains primary.

Purpose of the Study:

• * To comprehensively review the epidemiology, pathogenesis, clinical characteristics, and management of COVID-19.
• * To consolidate current evidence on SARS-CoV-2 for clinical understanding and disease management.
• * To emphasize the need for ongoing learning due to the rapidly evolving nature of COVID-19 research.

Main Methods:

• * Literature review synthesizing available evidence on COVID-19.
• * Analysis of epidemiological data, transmission routes, and clinical presentations.
• * Summary of current and investigational therapeutic and vaccine strategies.

Main Results:

• * COVID-19 is a highly transmissible respiratory illness with diverse clinical manifestations.
• * Supportive care is the cornerstone of management; specific treatments like dexamethasone and remdesivir show promise.
• * Over 150 vaccines are in development, indicating intensive global research efforts.

Conclusions:

• * Understanding SARS-CoV-2's nature and clinical profile is crucial for effective disease management.
• * Clinicians require regular updates on evolving COVID-19 knowledge.
• * Continued research into treatments and vaccines is essential to combat the pandemic.